Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;60(8):986-990.
doi: 10.1111/ijd.15519. Epub 2021 Mar 20.

Skin cancer in non-white liver transplant recipients: Mayo Clinic experience

Leila M Tolaymat  1 , Danielle K Reimer  1 , Joshua Feig  2 , Melinda S Gillis  3 , Leigh L Speicher  4 , Claire B Haga  5 , Emmanuel M Gabriel  6 , Michael G Heckman  7 , Mingyuan Yin  8 , Scott W Fosko  9 , Andrew P Keaveny  10   11 , Nancy L Dawson  4
Affiliations

Skin cancer in non-white liver transplant recipients: Mayo Clinic experience

Leila M Tolaymat et al. Int J Dermatol. 2021 Aug.

Abstract

Background: Limited data are available on the development of skin cancer and the associated risk factors for non-White liver transplant (LT) recipients. The aim of this study is to determine the incidence of newly diagnosed skin cancer postoperatively and to identify the risk factors for the development of skin cancer in non-White LT recipients.

Methods: We conducted an initial retrospective chart review of non-White LT patients who received a transplant at our center between January 1, 2011, and December 31, 2013.

Results: Of the 96 patients in the study cohort, 32% were Black, 17% were Asian, 15% were White Hispanic, and 10% were Black Hispanic. One patient had a history of nonmelanoma skin cancer before transplant. No skin cancers were diagnosed during follow-up (median, 1.3 years; range, 17 days to 8.6 years).

Conclusion: Our center's experience is consistent with the literature and suggests that the incidence of newly diagnosed skin cancer in non-White liver transplant recipients is low. Longer follow-up may provide additional insights into the specific risk factors for the posttransplant development of skin cancer.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None.

Similar articles

See all similar articles

Cited by

References

    1. United Network for Organ Sharing. Transplant trends. Available at: https://unos.org/data/transplant-trends/. [Accessed on 29 July 2020].
    1. Manzia TM, Angelico R, Gazia C, et al. De novo malignancies after liver transplantation: the effect of immunosuppression-personal data and review of literature. World J Gastroenterol 2019; 25: 5356–5375. - PMC - PubMed
    1. Bhat M, Mara K, Dierkhising R, et al. Gender, race and disease etiology predict de novo malignancy risk after liver transplantation: insights for future individualized cancer screening guidance. Transplantation 2019; 103: 91–100. - PubMed
    1. Garrett GL, Lowenstein SE, Singer JP, et al. Trends of skin cancer mortality after transplantation in the United States: 1987 to 2013. J Am Acad Dermatol 2016; 75: 106–112. - PubMed
    1. Garrett GL, Blanc PD, Boscardin J, et al. Incidence of and risk factors for skin cancer in organ transplant recipients in the United States. JAMA Dermatol 2017; 153: 296–303. - PubMed